{
  "retracted": false,
  "timestamp": 1545264000000,
  "updates": [
    {
      "timestamp": 1550535336462,
      "identifier": {
        "doi": "10.1007/s40263-018-0595-4"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s40263-018-0547-z"
  },
  "journal": "CNS Drugs",
  "publisher": "Springer Nature",
  "title": "Correction to: Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis"
}
